PILLIS
OFLOXACIN 0.75% w/w +ORNIDAZOLE 2%w/w+ITRANCONAZOLE1%w/w+CLOBETASOL PROPIONATE 0.5% w/w CREAM
Brand: PILLIS
MRP
₹140/-
Packaging
15 GMS
Form
ANTI-FUNGAL
Description & Usage
Ofloxacin, Ornidazole, Itraconazole And Clobetasol Propionate Cream
Ofloxacin 0.75% W/W, Ornidazole 2% W/W, Itraconazole 1% W/W, Clobetasol Propionate 0.5% W/W Cream is a topical dosage form manufactured using a combination of four important ingredients in the market. It occupies an essential position in derma product segment because it contains a blend of antibacterial, antifungal and corticosteroid based composition in the form of a single professional topical preparation.
The product finds an essential place in the portfolio of pharmaceutical companies manufacturing and supplying pharmaceutical products through the PCD pharma franchise, third party manufacturing, derma range marketing, and pharmaceutical distribution sector. The cream dosage form is considered convenient for packaging, storage, transportation and supplying across various pharmaceutical channels. Along with quality manufacturing, effective packaging and regular availability, the composition can emerge as a significant value to a professional derma product range.
Composition Profile And Topical Formulation Value
The active composition of this cream is Ofloxacin 0.75% W/W, Ornidazole 2% W/W, Itraconazole 1% W/W and Clobetasol Propionate 0.5% W/W. Ofloxacin is a well known topical ingredient found in various compositions. Ornidazole addition further enhances the product's value by combining it with other actives. Itraconazole adds value to the product in terms of its strong antifungal characteristic whereas Clobetasol Propionate brings forth the corticosteroid based component.
The cream base is manufactured using appropriate pharmaceutically acceptable excipients which are selected to ensure the product retains a smooth texture, spread ability, uniformity, stability, and desired shelf life. A cream that is manufactured to exhibit adequate dispersion of the active components throughout its base enhances the efficacy of the formulation's quality profile and hence its value in the market.
Dermatology Product Identity And Market Positioning
Ofloxacin, Ornidazole, Itraconazole And Clobetasol Propionate Cream has an identity as a derma product due to its multi-compositional nature. Topical products with such multi-active ingredients are usually part of a derma product range as they assist manufacturers in establishing a wider range of competitive creams for the consumers. A blend of these four active ingredients offers a unique presentation of the product and helps organizations in achieving superiority by adding advance derma products in their catalog.
For marketing purposes, the cream can be termed as a "professional derma cream with multi-spectrum activity." The power of the four actives can be showcased effectively using various marketing tools such as product visual aids, prescription pads, reminder cards, Mr bags, product literature, display materials, etc. For example, a broad derma range consisting of creams, ointments, gels, lotions, dusting powders and soaps helps a company capture more of the derma market and improve its brand equity.
Quality Manufacturing And Processing Standards
Manufacturing of Ofloxacin 0.75% W/W, Ornidazole 2% W/W, Itraconazole 1% W/W, Clobetasol Propionate 0.5% W/W Cream involves critical quality control parameters and stringent clean manufacturing processes. Reputable manufacturers follow the necessary guidelines to process quality raw material, suitable equipment, optimized processes and stringent procedures which maintain the cream's purity, efficacy, texture, stability and uniformity throughout the manufacturing and packaging phases. The processes must be supervised and monitored by technically qualified persons throughout to achieve and maintain standard pharmaceutical grade.
Quality assessment at various stages such as raw material analysis, base manufacturing and quality, mixing uniformity of the active ingredients within the base, pH and viscosity testing, texture assessment, tube filling and sealing parameters, final product analysis, and package inspection helps in ensuring that the product quality is always maintained within limits. Accurate distribution of all four actives in every batch of this cream becomes highly important as it is a multi-active compound. The manufacturing and packaging are performed according to the GMP guidelines which would support in achieving good branding for a quality product.
Packaging, Labeling And Brand Presentation
Packaging is very critical for the Ofloxacin, Ornidazole, Itraconazole And Clobetasol Propionate Cream as it keeps the product safe from leakage and contamination during transport and storage while at the same time offering an appeal to the consumer or healthcare professional. Laminated or aluminum tubes of suitable capacities are normally used along with visually appealing outer carton designs that can increase the product appeal. Good packaging also offers the convenience of handling, carrying and easy storage.
The tube should be designed with clear labels indicating Brand Name, generic Salt Name along with its respective concentration and amount, batch number, expiry date, MRP and manufacturing details, company information and storage recommendations, etc. Clearly legible prints and appropriate graphic design will increase the product's value and trustworthiness. It serves as a strong branding tool which will increase consumer awareness about the derma product in a dynamic market.
Market Demand And PCD Pharma Franchise Scope
Ofloxacin 0.75% W/W, Ornidazole 2% W/W, Itraconazole 1% W/W, Clobetasol Propionate 0.5% W/W Cream enjoys high demand as creams for derma products are always present in most general physician and derma product ranges. This will enhance an organization's offering with a quality and important topical product range. The product has high market value with respect to wholesalers, retailers, distributors, and in PCD Pharma franchise business as a multiple-ingredient based product. Most pharma organizations in the niche include these products for their derma range which also consists of products such as creams, ointments, gels, lotions, dusting powders, soaps, etc. It offers vast opportunities in the PCD pharma franchise as the same can be promoted by giving marketing strategies, visually enhanced inputs, sample supplies, prescription pad copies etc to the partners and can be offered along with a list of comprehensivederma and GMS range of products with monopoly rights, consistent supplies, timely dispatch and a good MRP structure.
Ofloxacin, Ornidazole, Itraconazole And Clobetasol Propionate Cream
Ofloxacin 0.75% W/W, Ornidazole 2% W/W, Itraconazole 1% W/W, Clobetasol Propionate 0.5% W/W Cream is a topical dosage form manufactured using a combination of four important ingredients in the market. It occupies an essential position in derma product segment because it contains a blend of antibacterial, antifungal and corticosteroid based composition in the form of a single professional topical preparation.
The product finds an essential place in the portfolio of pharmaceutical companies manufacturing and supplying pharmaceutical products through the PCD pharma franchise, third party manufacturing, derma range marketing, and pharmaceutical distribution sector. The cream dosage form is considered convenient for packaging, storage, transportation and supplying across various pharmaceutical channels. Along with quality manufacturing, effective packaging and regular availability, the composition can emerge as a significant value to a professional derma product range.
Composition Profile And Topical Formulation Value
The active composition of this cream is Ofloxacin 0.75% W/W, Ornidazole 2% W/W, Itraconazole 1% W/W and Clobetasol Propionate 0.5% W/W. Ofloxacin is a well known topical ingredient found in various compositions. Ornidazole addition further enhances the product's value by combining it with other actives. Itraconazole adds value to the product in terms of its strong antifungal characteristic whereas Clobetasol Propionate brings forth the corticosteroid based component.
The cream base is manufactured using appropriate pharmaceutically acceptable excipients which are selected to ensure the product retains a smooth texture, spread ability, uniformity, stability, and desired shelf life. A cream that is manufactured to exhibit adequate dispersion of the active components throughout its base enhances the efficacy of the formulation's quality profile and hence its value in the market.
Dermatology Product Identity And Market Positioning
Ofloxacin, Ornidazole, Itraconazole And Clobetasol Propionate Cream has an identity as a derma product due to its multi-compositional nature. Topical products with such multi-active ingredients are usually part of a derma product range as they assist manufacturers in establishing a wider range of competitive creams for the consumers. A blend of these four active ingredients offers a unique presentation of the product and helps organizations in achieving superiority by adding advance derma products in their catalog.
For marketing purposes, the cream can be termed as a "professional derma cream with multi-spectrum activity." The power of the four actives can be showcased effectively using various marketing tools such as product visual aids, prescription pads, reminder cards, Mr bags, product literature, display materials, etc. For example, a broad derma range consisting of creams, ointments, gels, lotions, dusting powders and soaps helps a company capture more of the derma market and improve its brand equity.
Quality Manufacturing And Processing Standards
Manufacturing of Ofloxacin 0.75% W/W, Ornidazole 2% W/W, Itraconazole 1% W/W, Clobetasol Propionate 0.5% W/W Cream involves critical quality control parameters and stringent clean manufacturing processes. Reputable manufacturers follow the necessary guidelines to process quality raw material, suitable equipment, optimized processes and stringent procedures which maintain the cream's purity, efficacy, texture, stability and uniformity throughout the manufacturing and packaging phases. The processes must be supervised and monitored by technically qualified persons throughout to achieve and maintain standard pharmaceutical grade.
Quality assessment at various stages such as raw material analysis, base manufacturing and quality, mixing uniformity of the active ingredients within the base, pH and viscosity testing, texture assessment, tube filling and sealing parameters, final product analysis, and package inspection helps in ensuring that the product quality is always maintained within limits. Accurate distribution of all four actives in every batch of this cream becomes highly important as it is a multi-active compound. The manufacturing and packaging are performed according to the GMP guidelines which would support in achieving good branding for a quality product.
Packaging, Labeling And Brand Presentation
Packaging is very critical for the Ofloxacin, Ornidazole, Itraconazole And Clobetasol Propionate Cream as it keeps the product safe from leakage and contamination during transport and storage while at the same time offering an appeal to the consumer or healthcare professional. Laminated or aluminum tubes of suitable capacities are normally used along with visually appealing outer carton designs that can increase the product appeal. Good packaging also offers the convenience of handling, carrying and easy storage.
The tube should be designed with clear labels indicating Brand Name, generic Salt Name along with its respective concentration and amount, batch number, expiry date, MRP and manufacturing details, company information and storage recommendations, etc. Clearly legible prints and appropriate graphic design will increase the product's value and trustworthiness. It serves as a strong branding tool which will increase consumer awareness about the derma product in a dynamic market.
Market Demand And PCD Pharma Franchise Scope
Ofloxacin 0.75% W/W, Ornidazole 2% W/W, Itraconazole 1% W/W, Clobetasol Propionate 0.5% W/W Cream enjoys high demand as creams for derma products are always present in most general physician and derma product ranges. This will enhance an organization's offering with a quality and important topical product range. The product has high market value with respect to wholesalers, retailers, distributors, and in PCD Pharma franchise business as a multiple-ingredient based product. Most pharma organizations in the niche include these products for their derma range which also consists of products such as creams, ointments, gels, lotions, dusting powders, soaps, etc. It offers vast opportunities in the PCD pharma franchise as the same can be promoted by giving marketing strategies, visually enhanced inputs, sample supplies, prescription pad copies etc to the partners and can be offered along with a list of comprehensivederma and GMS range of products with monopoly rights, consistent supplies, timely dispatch and a good MRP structure.